Investors Watch List: Huntington Bancshares Incorporated (NASDAQ:HBAN), Alcatel Lucent SA (ADR) (NYSE:ALU), Aeterna Zentaris Inc. (NASDAQ:AEZS), Pfizer Inc. (NYSE:PFE), Myers Industries (NYSE:MYE)

Huntington Bancshares Incorporated (NASDAQ:HBAN) belongs to Financial sector. Its net profit margin is 30.80% and weekly performance is -1.23%. On last trading day company shares ended up $11.21. Huntington Bancshares Incorporated (NASDAQ:HBAN) distance from 50-day simple moving average (SMA50) is -0.05%. Zacks upgraded shares of Huntington Bancshares Inc. (NASDAQ:HBAN) from a hold rating to a buy rating in a report.

Alcatel Lucent SA (ADR) (NYSE:ALU) ended the last trading day at $3.57. Company weekly volatility is calculated as 2.80% and price to cash ratio as 1.55. Alcatel Lucent SA (ADR) (NYSE:ALU) showed a weekly performance of -0.28%. The Spanish telco will expand its testing of Alcatel Lucent SA (ADR) (NYSE:ALU)’s virtual networking gear as part of its effort to use NFV in its environment. Alcatel Lucent SA (ADR) (NYSE:ALU) and Spanish telecommunications company Telefonica are expanding the work they’re doing together in testing network-functions virtualization technologies for service providers.

On 10 July, Aeterna Zentaris Inc. (NASDAQ:AEZS) shares increased 3.57% and was closed at $0.24. AEZS EPS growth in last 5 year was 30.40%. Aeterna Zentaris Inc. (NASDAQ:AEZS) year to date (YTD) performance is -60.30%. Aeterna Zentaris Inc. (NASDAQ:AEZS) declared that it has executed a definitive agreement with Ergomed PLC (“Ergomed”), following which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen™ (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency (“AGHD”).

Pfizer Inc. (NYSE:PFE) shares advanced 1.48% in last trading session and ended the day at $34.36. PFE Gross Margin is 81.00% and its return on assets is 6.80%. Pfizer Inc. (NYSE:PFE) quarterly performance is -2.25%. On 8 July, Pfizer Inc. (NYSE:PFE) announced enrollment of the first patient in a phase 2b clinical trial of its investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) in adults undergoing elective spinal fusion surgery.

Myers Industries Inc. (NYSE:MYE) shares increased 0.22% in last trading session and ended the day at $17.96. MYE Gross Margin is 26.20% and its return on assets is -0.60%. Myers Industries Inc. (NYSE:MYE) quarterly performance is 5.82%. Myers Industries Inc. (NYSE:MYE) intends to report its financial results for the second quarter ended June 30 on Thursday, July 23 before the market opens.

Leave a Reply

Your email address will not be published. Required fields are marked *